Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Tefferi A, Barbui T.
Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26.
PMID:37357958
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.
Gangat N, Singh A, Ilyas R, Loscocco GG, Elliott M, Begna K, Pardanani A, Tefferi A.
Am J Hematol. 2024 Oct;99(10):1862-1869. doi: 10.1002/ajh.27416. Epub 2024 Jun 12.
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS, Shehata N.
JAMA Netw Open. 2019 Oct 2;2(10):e1912666. doi: 10.1001/jamanetworkopen.2019.12666.
PMID:31584685
First successful pregnancy outcome after intrauterine insemination in a woman with primary infertility and essential thrombocythemia treated with interferon-alpha and aspirin.
Leković D, Gotić M, Ljubić A.
Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):210-3. doi: 10.2298/sarh1504210l.
PMID:26012134
Management of patients with essential thrombocythemia: current concepts and perspectives.